Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?

Shuichi Aoki; Mark Cobbold; Andrew X. Zhu; Dan G. Duda

doi:10.1002/hep.29617

Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?

Shuichi Aoki, Mark Cobbold, Andrew X. Zhu, Dan G. Duda

HOSP - Surgery

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Original language	English
Pages (from-to)	826-828
Number of pages	3
Journal	Hepatology
Volume	67
Issue number	3
DOIs	https://doi.org/10.1002/hep.29617
Publication status	Published - 2018 Mar

Access to Document

10.1002/hep.29617

Cite this

@article{9ab863813200446e8a85d8bfc72040f7,

title = "Can smart nanomedicine deliver effective targeted cytotoxic treatments to hepatocellular carcinomas while reducing the liver damage?",

author = "Shuichi Aoki and Mark Cobbold and Zhu, {Andrew X.} and Duda, {Dan G.}",

note = "Funding Information: Received October 10, 2017; accepted October 24, 2017. Dr. Duda{\textquoteright}s research is supported by NIH grants P01-CA080124 and R41CA213678 and by sponsored research agreements with Bayer, Exelixis, Leap Tx, Merrimack, and Bristol-Myers Squibb. Funding Information: Dr. Duda's research is supported by NIH grants P01-CA080124 and R41CA213678 and by sponsored research agreements with Bayer, Exelixis, Leap Tx, Merrimack, and Bristol-Myers Squibb",

year = "2018",

month = mar,

doi = "10.1002/hep.29617",

language = "English",

volume = "67",

pages = "826--828",

journal = "Hepatology",

issn = "0270-9139",